Published in J Clin Invest on April 01, 1993
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Redox control of the cell cycle in health and disease. Antioxid Redox Signal (2009) 1.72
Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. J Clin Invest (1997) 1.47
Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest (2000) 1.37
Vascular smooth muscle cell motility: From migration to invasion. Exp Clin Cardiol (2010) 1.33
Targeting non-malignant disorders with tyrosine kinase inhibitors. Nat Rev Drug Discov (2010) 1.24
Separation of the arterial wall from blood contact using hydrogel barriers reduces intimal thickening after balloon injury in the rat: the roles of medial and luminal factors in arterial healing. Proc Natl Acad Sci U S A (1996) 1.10
Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway. J Biol Chem (2010) 1.00
Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci U S A (1996) 0.99
Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest (1998) 0.93
Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest (1994) 0.92
Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler Thromb Vasc Biol (2014) 0.89
Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo. J Clin Invest (1997) 0.88
Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury. Sci Rep (2014) 0.84
Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. Front Horm Res (2014) 0.81
Gene therapy for cardiovascular disease. Br Heart J (1994) 0.81
Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery. J Korean Med Sci (2004) 0.79
Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol Med (1997) 0.79
The LDL receptor-related protein 1 (LRP1) regulates the PDGF signaling pathway by binding the protein phosphatase SHP-2 and modulating SHP-2- mediated PDGF signaling events. PLoS One (2013) 0.78
Regulation of vascular smooth muscle cell growth: targeting the final common pathway. Arterioscler Thromb Vasc Biol (2003) 0.77
Transplantation of EPCs overexpressing PDGFR-β promotes vascular repair in the early phase after vascular injury. BMC Cardiovasc Disord (2016) 0.75
Vascular disease: the next target for local molecular therapeutics. BMJ (1994) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature (1981) 13.89
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
The biology of platelet-derived growth factor. Cell (1986) 7.17
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
Calcium as a regulator of the proliferation of normal, but not of transformed, chicken fibroblasts in a plasma-containing medium. Proc Natl Acad Sci U S A (1971) 3.87
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science (1990) 3.27
Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A (1990) 2.90
Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science (1990) 2.63
Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest (1992) 2.62
Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science (1989) 1.95
Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels. Lab Invest (1986) 1.91
Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation (1991) 1.88
Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther (1992) 1.28
Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis. Proc Natl Acad Sci U S A (1992) 1.12
Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res (1992) 0.99
Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest (1992) 0.99
A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol (1994) 19.91
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A (1989) 11.76
Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics (1998) 11.25
Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science (1981) 10.62
Development of a preventive vaccine for Ebola virus infection in primates. Nature (2000) 8.32
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature (1988) 7.35
The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90
Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet (1998) 6.09
Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature (1989) 5.76
Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A (1979) 5.70
Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol (1985) 5.67
Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature (1991) 5.07
Estimation of primate speciation dates using local molecular clocks. Mol Biol Evol (2000) 5.06
Probability distribution of molecular evolutionary trees: a new method of phylogenetic inference. J Mol Evol (1996) 4.95
p53 inhibition by the LANA protein of KSHV protects against cell death. Nature (2000) 4.74
Diversity and depth-specific distribution of SAR11 cluster rRNA genes from marine planktonic bacteria. Appl Environ Microbiol (1997) 4.71
Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science (1997) 4.37
Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med (2000) 4.36
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Accuracy and power of the likelihood ratio test in detecting adaptive molecular evolution. Mol Biol Evol (2001) 4.03
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med (1997) 3.90
Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest (1991) 3.82
Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81
Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest (1988) 3.76
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J (1993) 3.74
The CLAVATA1 receptor-like kinase requires CLAVATA3 for its assembly into a signaling complex that includes KAPP and a Rho-related protein. Plant Cell (1999) 3.62
Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol (1994) 3.57
A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet (2001) 3.52
Microtubule-based transport systems in neurons: the roles of kinesins and dyneins. Annu Rev Neurosci (2000) 3.48
The causal links between stress and burnout in a longitudinal study of UK doctors. Lancet (2002) 3.45
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
Control of pollen tube tip growth by a Rop GTPase-dependent pathway that leads to tip-localized calcium influx. Plant Cell (1999) 3.32
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
Immunization for Ebola virus infection. Nat Med (1998) 3.27
Total synthesis of taxol. Nature (1994) 3.22
Patterns of tuberculosis transmission in Central Los Angeles. JAMA (1997) 3.21
Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis (1997) 3.18
Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med (2001) 3.11
Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol (1998) 3.11
CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J (1998) 3.06
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98
Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron (2000) 2.94
Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol (1996) 2.91
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am J Pathol (1987) 2.91
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest (1998) 2.90
Positive Darwinian selection drives the evolution of several female reproductive proteins in mammals. Proc Natl Acad Sci U S A (2001) 2.80
Rop GTPase-dependent dynamics of tip-localized F-actin controls tip growth in pollen tubes. J Cell Biol (2001) 2.80
Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (1994) 2.79
Hemodynamic regulation: investigation by spectral analysis. Am J Physiol (1985) 2.79
Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci U S A (1992) 2.72
PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem (2001) 2.67
p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol (2001) 2.64
Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science (1990) 2.63
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med (1993) 2.62
A cloned MCGF cDNA encodes a multilineage hematopoietic growth factor: multiple activities of interleukin 3. J Immunol (1985) 2.56
cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol (1992) 2.55
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
Regulation of the proinflammatory effects of Fas ligand (CD95L). Science (1998) 2.43
Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation (2001) 2.41
Periodic emission from the gamma-ray binary 1FGL J1018.6-5856. Science (2012) 2.40
The geography of availability and driving after drinking. Addiction (1996) 2.39
The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem (1998) 2.39
A smooth muscle-specific monoclonal antibody recognizes smooth muscle actin isozymes. J Cell Biol (1985) 2.38
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci U S A (1993) 2.35
Synthesis of epothilones A and B in solid and solution phase. Nature (1997) 2.35
Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science (1990) 2.33
An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng (1986) 2.31
Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29
Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol (1998) 2.27
An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol (1994) 2.26
Fibroblast growth factor 2 control of vascular tone. Nat Med (1998) 2.21
Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol (1998) 2.19
Arabidopsis Rho-related GTPases: differential gene expression in pollen and polar localization in fission yeast. Plant Physiol (1998) 2.18
Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord (2004) 2.15
Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac Radiol (2010) 2.15
Fine structure of vascular endothelium in culture. J Ultrastruct Res (1975) 2.15
Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol (2001) 2.12
DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med (1997) 2.11
Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J Biol Chem (1997) 2.04
Therapeutic angiogenesis in patients with advanced coronary artery disease: hype or hope? J Invasive Cardiol (1999) 2.03
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet (1995) 2.03
Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3). Mol Cell Biol (1993) 2.00
NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol (1998) 1.96
Expression of an Arabidopsis cryptochrome gene in transgenic tobacco results in hypersensitivity to blue, UV-A, and green light. Proc Natl Acad Sci U S A (1995) 1.96
Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A (2005) 1.95
Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science (1989) 1.95